IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 394 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,459,000 | -31.5% | 25,809 | -42.5% | 0.01% | -38.5% |
| Q3 2020 | $2,131,000 | -6.0% | 44,919 | +16.8% | 0.01% | -7.1% |
| Q2 2020 | $2,267,000 | -36.7% | 38,449 | -49.2% | 0.01% | -46.2% |
| Q1 2020 | $3,581,000 | -73.1% | 75,733 | -63.5% | 0.03% | -71.4% |
| Q2 2019 | $13,319,000 | -20.9% | 207,238 | -0.2% | 0.09% | -19.5% |
| Q1 2019 | $16,848,000 | +50.1% | 207,565 | 0.0% | 0.11% | +34.5% |
| Q4 2018 | $11,221,000 | +8.2% | 207,565 | +3.3% | 0.08% | +47.4% |
| Q3 2018 | $10,366,000 | +19.4% | 200,977 | -3.6% | 0.06% | +11.8% |
| Q2 2018 | $8,684,000 | -7.3% | 208,405 | -1.9% | 0.05% | -10.5% |
| Q1 2018 | $9,364,000 | -12.8% | 212,425 | -0.5% | 0.06% | -6.6% |
| Q4 2017 | $10,740,000 | +2.4% | 213,524 | +3.3% | 0.06% | +8.9% |
| Q3 2017 | $10,484,000 | +2.9% | 206,784 | +3.3% | 0.06% | -1.8% |
| Q2 2017 | $10,187,000 | – | 200,258 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,463,400 | $418,566,000 | 6.01% |
| Tweedy, Browne Co LLC | 2,722,988 | $120,438,000 | 5.30% |
| BVF INC/IL | 2,872,953 | $127,071,000 | 5.25% |
| Sicart Associates LLC | 253,976 | $11,233,000 | 3.98% |
| Parkman Healthcare Partners LLC | 241,945 | $10,701,000 | 3.04% |
| Camber Capital Management LP | 1,925,000 | $85,143,000 | 2.61% |
| Privium Fund Management B.V. | 148,807 | $6,589,000 | 2.39% |
| SECTOR GAMMA AS | 164,223 | $7,264,000 | 1.87% |
| HANSEATIC MANAGEMENT SERVICES INC | 10,993 | $486,000 | 1.31% |
| BRANDYWINE MANAGERS, LLC | 8,460 | $374,000 | 1.23% |